135 related articles for article (PubMed ID: 9245968)
21. Differentiation of hepatomas from nonhepatomatous masses: use of MnDPDP-enhanced MR images.
Liou J; Lee JK; Borrello JA; Brown JJ
Magn Reson Imaging; 1994; 12(1):71-9. PubMed ID: 8295510
[TBL] [Abstract][Full Text] [Related]
22. MnDPDP for MR imaging of the liver. Results from the European phase III studies.
Torres CG; Lundby B; Sterud AT; McGill S; Gordon PB; Bjerknes HS
Acta Radiol; 1997 Jul; 38(4 Pt 2):631-7. PubMed ID: 9245956
[TBL] [Abstract][Full Text] [Related]
23. General toxicology of MnDPDP.
Larsen LE; Grant D
Acta Radiol; 1997 Jul; 38(4 Pt 2):770-9. PubMed ID: 9245973
[TBL] [Abstract][Full Text] [Related]
24. Preclinical evaluation of MnDPDP: new paramagnetic hepatobiliary contrast agent for MR imaging.
Elizondo G; Fretz CJ; Stark DD; Rocklage SM; Quay SC; Worah D; Tsang YM; Chen MC; Ferrucci JT
Radiology; 1991 Jan; 178(1):73-8. PubMed ID: 1898538
[TBL] [Abstract][Full Text] [Related]
25. [Comparison of biphasic spiral CT and MnDPDP-enhanced MRI in the detection and characterization of liver lesions].
Grimm J; Müller-Hülsbeck S; Blume J; Biederer J; Heller M
Rofo; 2001 Mar; 173(3):266-72. PubMed ID: 11293872
[TBL] [Abstract][Full Text] [Related]
26. The reproductive toxicology of intravenously administered MnDPDP in the rat and rabbit.
Grant D; Blazak WF; Brown GL
Acta Radiol; 1997 Jul; 38(4 Pt 2):759-69. PubMed ID: 9245972
[TBL] [Abstract][Full Text] [Related]
27. Mangafodipir trisodium injection, a new contrast medium for magnetic resonance imaging: in vitro metabolism and protein binding studies of the active component MnDPDP in human blood.
Toft KG; Kindberg GM; Skotland T
J Pharm Biomed Anal; 1997 Apr; 15(7):983-8. PubMed ID: 9160265
[TBL] [Abstract][Full Text] [Related]
28. MnDPDP enhancement in rabbit liver after intravenous bolus injection and slow infusion.
Thorstensen O; Isberg B; Jorulf H; Westman L; Svahn U; Venizelos N
Acta Radiol; 1997 Jul; 38(4 Pt 2):717-23. PubMed ID: 9245967
[TBL] [Abstract][Full Text] [Related]
29. Mangafodipir trisodium injection, a new contrast medium for magnetic resonance imaging: detection and quantitation of the parent compound MnDPDP and metabolites in human plasma by high performance liquid chromatography.
Toft KG; Friisk GA; Skotland T
J Pharm Biomed Anal; 1997 Apr; 15(7):973-81. PubMed ID: 9160264
[TBL] [Abstract][Full Text] [Related]
30. Hepatobiliary MR imaging: first human experience with MnDPDP.
Lim KO; Stark DD; Leese PT; Pfefferbaum A; Rocklage SM; Quay SC
Radiology; 1991 Jan; 178(1):79-82. PubMed ID: 1898539
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. Multicenter phase III clinical trials. Efficacy of early imaging.
Federle M; Chezmar J; Rubin DL; Weinreb J; Freeny P; Schmiedl UP; Brown JJ; Borrello JA; Lee JK; Semelka RC; Mattrey R; Dachman AH; Saini S; Harms SE; Mitchell DG; Anderson MW; Halford HH; Bennett WF; Young SW; Rifkin M; Gay SB; Ballerini R; Sherwin PF; Robison RO
J Magn Reson Imaging; 2000 Nov; 12(5):689-701. PubMed ID: 11050638
[TBL] [Abstract][Full Text] [Related]
32. Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.
Reimer P; Schneider G; Schima W
Eur Radiol; 2004 Apr; 14(4):559-78. PubMed ID: 14986050
[TBL] [Abstract][Full Text] [Related]
33. Magnetic resonance imaging after arterial portography with manganese dipyridoxal diphosphate.
Nelson RC; Chezmar JL; Thompson GH; Webber JB; Garrison MH; Spencer HB; Dillehay DL
Invest Radiol; 1993 Apr; 28(4):335-40. PubMed ID: 8478175
[TBL] [Abstract][Full Text] [Related]
34. Manganese dipyridoxyl diphosphate (MnDPDP)-enhanced magnetic resonance imaging of acute reperfused myocardial injury in a cat model: part II: comparison with cine magnetic resonance imaging.
Yang DH; Kim TH; Choi JW; Kim ST; Yoon JH; Shin JH; Seo JB; Lim TH
Invest Radiol; 2005 Jan; 40(1):56-61. PubMed ID: 15597021
[TBL] [Abstract][Full Text] [Related]
35. Mangafodipir trisodium injection (Mn-DPDP). A contrast agent for abdominal MR imaging.
Rofsky NM; Earls JP
Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):73-85. PubMed ID: 8673718
[TBL] [Abstract][Full Text] [Related]
36. Developmental toxicity study of mangafodipir trisodium injection (MnDPDP) in New Zealand white rabbits.
Blazak WF; Brown GL; Gray TJ; Treinen KA; Denny KH
Fundam Appl Toxicol; 1996 Sep; 33(1):11-5. PubMed ID: 8812204
[TBL] [Abstract][Full Text] [Related]
37. Improved image contrast with mangafodipir trisodium (MnDPDP) during MR-guided percutaneous cryosurgery of the liver.
Traoré AS; Godbout MJ; Serre D; Younan R; Dionne G; Dufour M; Morin J; Moisan C
Magn Reson Imaging; 2003 Jul; 21(6):609-15. PubMed ID: 12915191
[TBL] [Abstract][Full Text] [Related]
38. Sequential use of gadolinium chelate and mangafodipir trisodium for the assessment of focal liver lesions: initial observations.
Martin DR; Semelka RC; Chung JJ; Balci NC; Wilber K
Magn Reson Imaging; 2000 Oct; 18(8):955-63. PubMed ID: 11121698
[TBL] [Abstract][Full Text] [Related]
39. Detection of hepatic metastasis: manganese- and ferucarbotran-enhanced MR imaging.
Choi JY; Kim MJ; Kim JH; Kim SH; Ko HK; Lim JS; Oh YT; Chung JJ; Yoo HS; Lee JT; Kim KW
Eur J Radiol; 2006 Oct; 60(1):84-90. PubMed ID: 16920315
[TBL] [Abstract][Full Text] [Related]
40. Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT.
Bartolozzi C; Donati F; Cioni D; Procacci C; Morana G; Chiesa A; Grazioli L; Cittadini G; Cittadini G; Giovagnoni A; Gandini G; Maass J; Lencioni R
Eur Radiol; 2004 Jan; 14(1):14-20. PubMed ID: 14730384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]